NO20073909L - Forstover-formulering - Google Patents
Forstover-formuleringInfo
- Publication number
- NO20073909L NO20073909L NO20073909A NO20073909A NO20073909L NO 20073909 L NO20073909 L NO 20073909L NO 20073909 A NO20073909 A NO 20073909A NO 20073909 A NO20073909 A NO 20073909A NO 20073909 L NO20073909 L NO 20073909L
- Authority
- NO
- Norway
- Prior art keywords
- nebulized formulation
- nebulized
- formulation
- ipratropium
- copd
- Prior art date
Links
- 238000009472 formulation Methods 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 title abstract 2
- 208000023504 respiratory system disease Diseases 0.000 abstract 2
- NDAUXUAQIAJITI-LBPRGKRZSA-N (R)-salbutamol Chemical compound CC(C)(C)NC[C@H](O)C1=CC=C(O)C(CO)=C1 NDAUXUAQIAJITI-LBPRGKRZSA-N 0.000 abstract 1
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 abstract 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 abstract 1
- 208000006673 asthma Diseases 0.000 abstract 1
- OEXHQOGQTVQTAT-JRNQLAHRSA-N ipratropium Chemical compound O([C@H]1C[C@H]2CC[C@@H](C1)[N@@+]2(C)C(C)C)C(=O)C(CO)C1=CC=CC=C1 OEXHQOGQTVQTAT-JRNQLAHRSA-N 0.000 abstract 1
- 229960001888 ipratropium Drugs 0.000 abstract 1
- 229950008204 levosalbutamol Drugs 0.000 abstract 1
- 239000006199 nebulizer Substances 0.000 abstract 1
- 239000011780 sodium chloride Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
- A61K31/37—Coumarins, e.g. psoralen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Emergency Medicine (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dispersion Chemistry (AREA)
- Otolaryngology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
En nebulisator-formulering som inneholder levalbuterol og ipratropium i omtrent 2 ml eller mindre saltvann og som anvendes for behandling av COPD og astma og andre luftveissykdommer og lidelser med økt pasient-medgjørlighet.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0501956.7A GB0501956D0 (en) | 2005-01-31 | 2005-01-31 | Nebulizer formulation |
PCT/GB2006/000309 WO2006079841A1 (en) | 2005-01-31 | 2006-01-30 | Nebulizer formulation |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20073909L true NO20073909L (no) | 2007-10-24 |
Family
ID=34307728
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20073909A NO20073909L (no) | 2005-01-31 | 2007-07-25 | Forstover-formulering |
Country Status (17)
Country | Link |
---|---|
US (1) | US20080319006A1 (no) |
EP (1) | EP1843750B1 (no) |
JP (1) | JP2008528565A (no) |
KR (1) | KR20070101292A (no) |
CN (2) | CN102631344A (no) |
AU (1) | AU2006208880B2 (no) |
BR (1) | BRPI0606261A2 (no) |
CA (1) | CA2596215A1 (no) |
CZ (1) | CZ2007598A3 (no) |
ES (1) | ES2441733T3 (no) |
GB (1) | GB0501956D0 (no) |
IL (1) | IL183578A0 (no) |
IS (1) | IS8666A (no) |
NO (1) | NO20073909L (no) |
NZ (1) | NZ556714A (no) |
WO (1) | WO2006079841A1 (no) |
ZA (1) | ZA200704977B (no) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0700380D0 (en) | 2007-01-09 | 2007-02-14 | Breath Ltd | Storage Of Ampoules |
US20090215734A1 (en) * | 2008-02-26 | 2009-08-27 | Elevation Pharmaceuticals, Inc. | Method and system for the treatment of chronic obstructive pulmonary disease with nebulized anticholinergic administrations |
US20100055045A1 (en) | 2008-02-26 | 2010-03-04 | William Gerhart | Method and system for the treatment of chronic obstructive pulmonary disease with nebulized anticholinergic administrations |
CN102166213A (zh) * | 2009-11-12 | 2011-08-31 | 北京利乐生制药科技有限公司 | 以左旋沙丁胺醇与异丙托溴铵为活性成分的组合物 |
CN107995861A (zh) * | 2015-05-18 | 2018-05-04 | 格兰马克专业公司 | 用于雾化的泰乌托品吸入溶液 |
WO2017157265A1 (zh) * | 2016-03-15 | 2017-09-21 | 广东东阳光药业有限公司 | 喷雾剂、喷雾装置以及喷雾组件 |
WO2021188809A1 (en) * | 2020-03-19 | 2021-09-23 | Cai Gu Huang | Inhalable formulation of a solution containing levalbuterol tartrate |
Family Cites Families (68)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3505337A (en) | 1967-12-22 | 1970-04-07 | Boehringer Sohn Ingelheim | N - hydrocarbyl-substituted noratropinium,haloalkylates and o-acyl derivatives thereof |
JPH0720862B2 (ja) * | 1989-01-27 | 1995-03-08 | ヘキスト・アクチエンゲゼルシヤフト | 吸入用喘息治療剤 |
JP2704546B2 (ja) * | 1989-04-04 | 1998-01-26 | 光利 太良 | Atll治療用吸入剤 |
US5362755A (en) * | 1990-01-05 | 1994-11-08 | Sepracor, Inc. | Method for treating asthma using optically pure (R)-albuterol |
CA2073181C (en) * | 1990-01-05 | 2002-04-23 | Timothy J. Barberich | Optically pure r(-) albuterol for treating asthma |
HU0004452D0 (no) * | 1991-12-18 | 2001-01-29 | Astra Ab | |
CZ284203B6 (cs) * | 1992-12-09 | 1998-09-16 | Boehringer Ingelheim Pharmaceuticals Inc. | Tekutý aerosolový přípravek obsahující léčivo a způsob stabilisace tohoto prostředku |
US5934272A (en) * | 1993-01-29 | 1999-08-10 | Aradigm Corporation | Device and method of creating aerosolized mist of respiratory drug |
JPH0892098A (ja) * | 1994-09-27 | 1996-04-09 | Teijin Ltd | 肺結核治療剤 |
US5603918A (en) * | 1995-06-09 | 1997-02-18 | Boehringer Ingelheim Pharmaceuticals, Inc. | Aerosol composition of a salt of ipratropium and a salt of albuterol |
US6571790B1 (en) * | 1997-05-12 | 2003-06-03 | Robert E. Weinstein | Method and device for organizing and coordinating the combined use of liquid medications for continuous nebulization for the treatment of respiratory disorders |
US7963955B2 (en) * | 1998-02-27 | 2011-06-21 | Boehringer Ingelheim International Gmbh | Container for a medicinal liquid |
US6685691B1 (en) * | 1998-02-27 | 2004-02-03 | Boehringer Ingelheim Gmbh | Container for a medicinal liquid |
GB9807232D0 (en) * | 1998-04-03 | 1998-06-03 | Univ Cardiff | Aerosol composition |
US6423298B2 (en) * | 1998-06-18 | 2002-07-23 | Boehringer Ingelheim Pharmaceuticals, Inc. | Pharmaceutical formulations for aerosols with two or more active substances |
DE59911149D1 (de) * | 1998-07-24 | 2004-12-30 | Jago Res Ag Muttenz | Medizinische aerosolformulierungen |
ATE234604T1 (de) * | 1998-08-04 | 2003-04-15 | Jago Res Ag | Medizinische aerosolformulierungen |
US7074388B2 (en) * | 1998-12-10 | 2006-07-11 | Kos Life Science, Inc. | Water stabilized medicinal aerosol formulation |
US6261539B1 (en) * | 1998-12-10 | 2001-07-17 | Akwete Adjei | Medicinal aerosol formulation |
US6962151B1 (en) * | 1999-11-05 | 2005-11-08 | Pari GmbH Spezialisten für effektive Inhalation | Inhalation nebulizer |
US6451289B2 (en) * | 2000-03-24 | 2002-09-17 | Sepracor Inc. | Albuterol formulations |
GB0012260D0 (en) * | 2000-05-19 | 2000-07-12 | Astrazeneca Ab | Novel composition |
US20060257324A1 (en) * | 2000-05-22 | 2006-11-16 | Chiesi Farmaceutici S.P.A. | Pharmaceutical solution formulations for pressurised metered dose inhalers |
AU2000250701B2 (en) * | 2000-05-22 | 2004-07-01 | Chiesi Farmaceutici S.P.A. | Stable pharmaceutical solution formulations for pressurised metered dose inhalers |
US6667314B2 (en) * | 2000-05-26 | 2003-12-23 | Pfizer, Inc. | Tropane derivatives useful in therapy |
CZ301676B6 (cs) * | 2001-03-30 | 2010-05-19 | Jagotec Ag | Farmaceutický suspenzní aerosolový prípravek pro inhalaci a použití soli karboxylové kyseliny |
US6667344B2 (en) * | 2001-04-17 | 2003-12-23 | Dey, L.P. | Bronchodilating compositions and methods |
US6455028B1 (en) * | 2001-04-23 | 2002-09-24 | Pharmascience | Ipratropium formulation for pulmonary inhalation |
DE10130371A1 (de) * | 2001-06-23 | 2003-01-02 | Boehringer Ingelheim Pharma | Neue Arzneimittelkompositionen auf der Basis von Anticholinergika, Corticosteroiden und Betamimetika |
JP2005508220A (ja) * | 2001-10-24 | 2005-03-31 | パーリ・ゲーエムベーハー | 薬用組成物調製用具 |
US20050175544A1 (en) * | 2001-10-26 | 2005-08-11 | Dey Lp | Albuterol inhalation solution, system, kit and method for relieving symptoms of pediatric asthma |
US20030191151A1 (en) * | 2001-10-26 | 2003-10-09 | Imtiaz Chaudry | Albuterol and ipratropium inhalation solution, system, kit and method for relieving symptoms of chronic obstructive pulmonary disease |
US8084461B2 (en) * | 2001-10-26 | 2011-12-27 | Dey, L.P. | Albuterol and ipratropium inhalation solution, system, kit and method for relieving symptoms of chronic obstructive pulmonary disease |
AU3297402A (en) * | 2001-10-26 | 2003-10-30 | Dey, L.P. | An albuterol and ipratropium inhalation solution, system, kit and method for relieving symptoms of chronic obstructive pulmonary disease |
US6702997B2 (en) * | 2001-10-26 | 2004-03-09 | Dey, L.P. | Albuterol inhalation solution, system, kit and method for relieving symptoms of pediatric asthma |
US20030203930A1 (en) * | 2001-10-26 | 2003-10-30 | Imtiaz Chaudry | Albuterol and ipratropium inhalation solution, system, kit and method for relieving symptoms of chronic obstructive pulmonary disease |
JP2003221335A (ja) * | 2001-10-26 | 2003-08-05 | Dey Lp | 慢性閉塞性肺疾患の症状を緩和するためのアルブテロールおよびイプラトロピウム吸入溶液、システム、キットおよび方法 |
US6974803B2 (en) * | 2001-12-06 | 2005-12-13 | Pfizer Inc | Pharmaceutical combination |
US7084153B2 (en) * | 2002-04-12 | 2006-08-01 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Medicaments comprising steroids and a novel anticholinergic |
US20040241103A1 (en) * | 2002-09-10 | 2004-12-02 | 3M Innovative Properties Company | Pharmaceutical aerosol compositions |
EP1417958A1 (en) * | 2002-11-08 | 2004-05-12 | Pari GmbH | Wet granulation process |
US7550133B2 (en) * | 2002-11-26 | 2009-06-23 | Alexza Pharmaceuticals, Inc. | Respiratory drug condensation aerosols and methods of making and using them |
CA2516634A1 (en) * | 2003-02-27 | 2004-09-10 | F. Hoffmann-La Roche Ag | Ccr-3 receptor antagonists |
BRPI0408547A (pt) * | 2003-03-20 | 2006-03-07 | Boehringer Ingelheim Pharma | formulação para um inalador com dosador usando hidro-flúor-alcanos como propelentes |
MXPA05010161A (es) * | 2003-03-28 | 2005-11-16 | Altana Pharma Ag | Combinacion sinergistica que comprende roflumilast y un agente anticolinergico seleccionado a partir de sales de ipratropio, oxitropio y tiotropio para el tratamiento de enfermedades respiratorias. |
US20040265238A1 (en) * | 2003-06-27 | 2004-12-30 | Imtiaz Chaudry | Inhalable formulations for treating pulmonary hypertension and methods of using same |
US20060251711A1 (en) * | 2003-08-28 | 2006-11-09 | Vgsk Technologies, Inc. | Sterically stabilized carrier for aerosol therapeutics, compositions and methods for treating diseases of the respiratory tract of a mammal |
DE10347994A1 (de) * | 2003-10-15 | 2005-06-16 | Pari GmbH Spezialisten für effektive Inhalation | Wässrige Aerosol-Zubereitung |
US9308199B2 (en) * | 2004-04-29 | 2016-04-12 | Honeywell International Inc. | Medicament formulations |
EP1686960A4 (en) * | 2003-10-28 | 2007-03-07 | Glaxo Group Ltd | INHALABLE PHARMACEUTICAL PREPARATIONS EMPLOYING LACTOSE ANHYDRATE, AND METHODS OF ADMINISTERING SAID PREPARATIONS |
US20050287077A1 (en) * | 2004-02-10 | 2005-12-29 | James E. Shipley | Process for preparing stable SOL of pharmaceutical ingredients and hydrofluorocarbon |
JP2007528408A (ja) * | 2004-03-11 | 2007-10-11 | セラヴァンス, インコーポレーテッド | ムスカリンレセプターアンタゴニストとしての有用なビフェニル化合物 |
TWI341836B (en) * | 2004-03-11 | 2011-05-11 | Theravance Inc | Biphenyl compounds useful as muscarinic receptor antagonists |
US20070260212A1 (en) * | 2004-06-08 | 2007-11-08 | Coifman Robert E | Ampules for Small Unit Dose Volumes of Drug |
JP5209963B2 (ja) * | 2004-07-02 | 2013-06-12 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 噴霧剤としてtg227ea又はtg134aを含有するエアロゾル懸濁製剤 |
US20080027094A1 (en) * | 2004-08-30 | 2008-01-31 | Ono Pharmaceutical Co., Ltd. | Tropane Compounds and Pharmaceutical Compositions Comprising the Same as an Active Ingredient |
US20070264202A1 (en) * | 2004-09-09 | 2007-11-15 | Cipla Limited | Pharmaceutical Composition Comprising an Isomer of Betamimetic Agent and an Anti-Cholinergic Agent |
GB0422413D0 (en) * | 2004-10-08 | 2004-11-10 | Breath Ltd | High efficiency nebulisation |
GB2437464A (en) * | 2004-12-03 | 2007-10-24 | Thirumalai Anandampilla Aparna | A resonating (alerting) metered dose inhaler |
US20060120967A1 (en) * | 2004-12-07 | 2006-06-08 | Qpharma, Llc | Solution forms of cyclodextrins for nasal or throat delivery of essential oils |
RU2440972C2 (ru) * | 2004-12-17 | 2012-01-27 | Сипла Лимитед | Кристаллический сульфат левосальбутамола, способ его получения и фармацевтическая композиция, содержащая его |
FR2879574B1 (fr) * | 2004-12-17 | 2011-01-21 | Valois Sas | Dispositif de distribution de produit fluide. |
US20060140873A1 (en) * | 2004-12-27 | 2006-06-29 | Chang Heng W | Aerosol pharmaceutical compositions |
JP2008542332A (ja) * | 2005-05-31 | 2008-11-27 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 呼吸器疾患治療用新規医薬組成物 |
WO2007020204A2 (en) * | 2005-08-12 | 2007-02-22 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Hfc solution formulations for inhalation containing salbutamol hydrochloride or salbutamol citrate |
US20070293460A1 (en) * | 2005-10-31 | 2007-12-20 | Richie's Pharmacy And Medical Supply, Incorporated | Delivery of a combination therapy for asthma and chronic obstructive pulmonary disease |
US20070202055A1 (en) * | 2006-02-09 | 2007-08-30 | Julianne Berry | Pharmaceutical Formulations |
GB0604141D0 (en) * | 2006-03-01 | 2006-04-12 | Arrow Int Ltd | Nebulizer formulation |
-
2005
- 2005-01-31 GB GBGB0501956.7A patent/GB0501956D0/en not_active Ceased
-
2006
- 2006-01-30 WO PCT/GB2006/000309 patent/WO2006079841A1/en active Application Filing
- 2006-01-30 CN CN2012100921125A patent/CN102631344A/zh active Pending
- 2006-01-30 AU AU2006208880A patent/AU2006208880B2/en not_active Ceased
- 2006-01-30 NZ NZ556714A patent/NZ556714A/en not_active IP Right Cessation
- 2006-01-30 ZA ZA200704977A patent/ZA200704977B/xx unknown
- 2006-01-30 JP JP2007552724A patent/JP2008528565A/ja active Pending
- 2006-01-30 CN CNA2006800015509A patent/CN101090709A/zh active Pending
- 2006-01-30 ES ES06701649.3T patent/ES2441733T3/es active Active
- 2006-01-30 CA CA002596215A patent/CA2596215A1/en not_active Abandoned
- 2006-01-30 CZ CZ20070598A patent/CZ2007598A3/cs unknown
- 2006-01-30 EP EP06701649.3A patent/EP1843750B1/en not_active Revoked
- 2006-01-30 KR KR1020077017260A patent/KR20070101292A/ko not_active Application Discontinuation
- 2006-01-30 US US11/815,085 patent/US20080319006A1/en not_active Abandoned
- 2006-01-30 BR BRPI0606261-0A patent/BRPI0606261A2/pt not_active IP Right Cessation
-
2007
- 2007-05-31 IL IL183578A patent/IL183578A0/en unknown
- 2007-07-25 NO NO20073909A patent/NO20073909L/no not_active Application Discontinuation
- 2007-08-02 IS IS8666A patent/IS8666A/is unknown
Also Published As
Publication number | Publication date |
---|---|
KR20070101292A (ko) | 2007-10-16 |
JP2008528565A (ja) | 2008-07-31 |
AU2006208880A1 (en) | 2006-08-03 |
IL183578A0 (en) | 2009-02-11 |
CA2596215A1 (en) | 2006-08-03 |
EP1843750B1 (en) | 2013-10-16 |
ES2441733T3 (es) | 2014-02-06 |
ZA200704977B (en) | 2008-11-26 |
BRPI0606261A2 (pt) | 2009-06-13 |
IS8666A (is) | 2007-08-02 |
CZ2007598A3 (cs) | 2007-10-17 |
WO2006079841A1 (en) | 2006-08-03 |
CN102631344A (zh) | 2012-08-15 |
AU2006208880B2 (en) | 2010-08-26 |
US20080319006A1 (en) | 2008-12-25 |
NZ556714A (en) | 2009-12-24 |
EP1843750A1 (en) | 2007-10-17 |
CN101090709A (zh) | 2007-12-19 |
GB0501956D0 (en) | 2005-03-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20083683L (no) | Nebulisatorformulering | |
NO20073909L (no) | Forstover-formulering | |
UY26959A1 (es) | Nuevos polvos para inhalación que contienen tiotropio | |
CY1117571T1 (el) | Συνδυασμος αντιχολινεργικων και ανταγωνιστων υποδοχεα λευκοτριενιου για την αγωγη αναπνευστικων νοσηματων | |
ATE421325T1 (de) | Kombination von methylxanthinverbindungen und steroiden zur behandlung chronischer atemwegserkrankungen | |
NO20063879L (no) | Kombinasjonen av antikolinergier og glukokortikoider for langsiktig behandling av astma og KOLS | |
UA98136C2 (ru) | Применение аклидиния для лечения респираторных заболеваний | |
ATE330589T1 (de) | Pharmazeutische zusammensetzung enthaltend resveratrol zur behandlung von entzündlichen erkrankungen der atemwege | |
CY1108326T1 (el) | ΝΕΟΣ ΣΥΝΔΥΑΣΜΟΣ ΑΝΤΙΧΟΛΙΝΕΡΓΙΚΩΝ ΚΑΙ β ΜΙΜΗΤΙΚΩΝ ΓΙΑ ΤΗΝ ΘΕΡΑΠΕΙΑ ΑΝΑΠΝΕΥΣΤΙΚΩΝ ΑΣΘΕΝΕΙΩΝ | |
UY27757A1 (es) | Medicamento que contiene betamiméticos y un nuevo anticolinérgico. | |
CY1106430T1 (el) | Φαρμακα για εισπνοη που πepιλαμβανουν βηταμιμητικα και αντιχολινepγικο | |
ECSP055855A (es) | Medicamentos en polvo para inhalación que contiene una sal de tiotropio y salmeterolxinafoato | |
NO20063047L (no) | Vandige ciclesonidsuspensjoner for forstoving | |
MX2021012723A (es) | Inhalador de presión positiva para entrega de medicamento inhalable y métodos para uso. | |
MY146628A (en) | Novel crystalline anhydride with anticholinergic effect | |
CY1114157T1 (el) | Αλατα του τιοτροπιου, μεθοδος για την παραγωγη τους και φαρμακευτικα σκευασματα που τα περιεχουν | |
RS20060293A (en) | Novel tiotropium salts, methods for the production thereof, and pharmaceutical formulations containing the same | |
CY1108420T1 (el) | Προτοτυπο τιοτροπιουχο κονιωδες σκευασμα για εισπνοη | |
HUP0002859A2 (hu) | A nitrogén-monoxidot kibocsátó vegyületek alkalmazása rinovírus-fertőzés által előidézett kórtünetek enyhítésére | |
EA201201392A1 (ru) | Кнопочное устройство мундштука ингалятора сухого порошка | |
EA200701077A1 (ru) | Применение конъюгатов липидов при лечении заболеваний | |
MXPA04007294A (es) | Composicion para inhalacion. | |
BR112019007259A2 (pt) | recipiente de câmara dupla adequado para uso com um nebulizador e pré-carregado com uma composição nebulizável, kit, composição nebulizável, solução nebulizável aquosa, método para administrar de tiotrópio e formoterol a um paciente com necessidade do mesmo e método para preparar um nebulizador | |
RU2006120506A (ru) | Способ лечения псориаза у детей | |
Miles | Addressing the legacy of coal |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |